FDA bans products from India's Canton; Sibelius resigns;

@FiercePharma: Natco looking to block Indian patent for Gilead's Sovaldi. Story | Follow @FiercePharma

@TracyStaton: FiercePharma's best-read marketing story: Sanofi aims for outcomes with new Chief Patient Officer. More | Follow @TracyStaton

@EricPFierce: RT from FiercePharma: AbbVie partners with Arabio for production in Saudi Arabia. Article | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: Our latest issue of FierceVaccines. More | Follow @CarlyHFierce

> The FDA has issued an import alert, banning products from Canton Laboratories in India after issuing a warning letter to one of its plants last month. Story

> Health and Human Services (HHS) Secretary Kathleen Sebelius is resigning, leading many to speculate on the future of the Affordable Care Act. News

> In a Phase II trial, Gilead's ($GILD) Sovaldi performed well in hepatitis patients with severe liver disease. More

> Pfizer ($PFE) CEO Ian Read was elected chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) Friday, while Merck ($MRK) CEO Kenneth Frazier became chairman-elect of the PhRMA board of directors and George Scangos, CEO of Biogen Idec, a board treasurer. Release

> Georgia Governor Nathan Deal is working on a way to legalize medical marijuana for treatment of children with seizure disorders after a bill to do so died in the Georgia legislature last month. Story

Medical Device News

@FierceMedDev: Boston Scientific launches a new clinical trial of its deep brain stimulation device. More | Follow @FierceMedDev

@VarunSaxena2: Deerfield bets on robotic surgery with OMNIlife science deal. Article | Follow @VarunSaxena2

@EmilyWFierce: "Molecular tweezers" could help prevent degenerative diseases like Alzheimer's or Parkinson's, say scientists at UCLA. Article | Follow @EmilyWFierce

@MichaelGFierce: ICYMI: 'Computer' made with DNA nanorobots delivers compounds in live cockroach. More from FierceDrugDelivery | Follow @MichaelGFierce

> Mainstay Medical sets its sights on a €23 million IPO. Story

> Smith & Nephew puts up $12M to clear the way for its $1.7B ArthroCare deal. More

> AngioDynamics boosts revenue as its turnaround stays on track. News

Biotech News

@FierceBiotech: Chimerix CEO Moch steps down after compassionate-use controversy. More | Follow @FierceBiotech

@JohnCFierce: Bayer backs VC fund, FBI calls Russian VCs thieves, Oryzon and Serendex plan IPOs. EuroBiotech Report | Follow @JohnCFierce

@DamianFierce: As Gilead gets pilloried over pricing, Bristol-Myers Squibb (Report) and Merck (Report) creep up in hep C. | Follow @DamianFierce

@EmilyMFierce: 'Not messing around': Ill. health official taking infectious tuberculosis patient to court. Story | Follow @EmilyMFierce

> Three IPO hopefuls look to squeeze out $144M as biotech gets bearish. News

> VCs gamble $45M on PhII pain drug, new U.S. base for Spinifex. More

> AbbVie angles for hep C spotlight as Merck shoulders to the front. Story

And Finally... Milk consumption may slow the progression of knee arthritis, a study found. More (sub. req.)